A double-masked study to compare the efficacy and safety of topical cromolyn for the treatment of allergic conjunctivitis

Journal of the Formosan Medical Association

Volumn 110, Issue 11, 2011, Pages 690-694

  Liu, Yao lin ^a   Hu, Fung Rong ^a   Wang, I Jong ^a   Chen, Wei Li ^a   Hou, Yu Chih ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Allergic conjunctivitis; Cromolyn; Ocular condition; Preservative

Indexed keywords

BENZALKONIUM CHLORIDE; CROMOGLYCATE DISODIUM; EYE DROPS;

ADULT; AGED; ALLERGIC CONJUNCTIVITIS; ARTICLE; CHEMOSIS; CLINICAL ARTICLE; CONJUNCTIVA DISEASE; CONJUNCTIVA REDNESS; CONTROLLED STUDY; CORNEA EROSION; DRUG EFFICACY; DRUG SAFETY; FOREIGN BODY; HOSPITAL DISCHARGE; HUMAN; OCULAR PRURITUS; PARALLEL DESIGN; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SLIT LAMP; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; BENZALKONIUM COMPOUNDS; CONJUNCTIVITIS, ALLERGIC; CROMOLYN SODIUM; DOUBLE-BLIND METHOD; HUMANS; MAST CELLS; MIDDLE AGED;

EID: 82255175691     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.09.004     Document Type: Article

References (21)

1. Abelson M.B., George M.A., Garofalo C. Differential diagnosis of ocular allergic disorders. Ann Allergy 1993, 70:95-109.
2. Canonica G.W., Ciprandi G., Petzold U., Kolb C., Ellers-Lenz B., Hermann R. Topical azelastine in perennial allergic conjunctivitis. Curr Med Res Opin 2003, 19:321-329.
3. Abelson M.B., Allansmith M.R. Histamine in the eye. Immunol immunopathol eye 1997, 362-364. Masson Publishing, New York. A. Silverstein, G. O'Connor (Eds.).
4. Leonardi A. Role of histamine in allergic conjunctivitis. Acta Ophthalmol Scand 2000, 78:18-21.
5. Butrus S., Portela R. Ocular allergy: diagnosis and treatment. Ophthalmol Clin North Am 2005, 18:485-492.
6. Brogden R.N., Speight T.M., Avery G.S. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drug 1974, 7:164-182.
7. Edwards A.M. The discovery of cromolyn sodium and its effect on research and practice in allergy and immunology. J Allergy Clin Immunol 2005, 115:885-888.
8. Jay J.L. Clinical features and diagnosis of adult atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthalmol 1981, 65:335-340.
9. Olson R.J., White G.L. Preservatives in ophthalmic topical medications: a significant cause of disease. Cornea 1990, 9:363-364.
10. Tipathi B.J., Tripathi R.C., Kolli S.P. Cytotoxicity of ophthalmic preservatives on human corneal epithelium. Lens Eye Toxic Res 1992, 9:361-375.
11. Lapalus P., Ettaiche M., Fredj-Reygrobellet D., Jambou D., Elena P.P. Cytotoxicity studies in ophthalmology. Lens Eye Toxic Res 1990, 7:231-242.
12. Epstein S.P., Ahdoot M., Marcus E., Asbell P.A. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 2009, 25:113-119.
13. Pauly A., Meloni M., Brignole-Baudouin F., Warnet J.M., Baudouin C. Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Invest Ophthalmol Vis Sci 2009, 50:1644-1652.
14. Nuzzi R., Finazzo C., Cerruti A. Adverse effects of topical antiglaucomatous medications on the conjunctiva and lachrymal response. Int Ophthalmol 1998, 22:31-35.
15. Xiong C., Chen D., Liu J., Liu B., Li N., Zhou Y., et al. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 2008, 49:1850-1856.
16. Noecker R.J., Herrygers L.A., Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 2004, 23:490-496.
17. Baudouin C., Liang H., Hamard P., Riancho L., Creuzot-Garcher C., Warnet J.M., et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 2008, 115:109-115.
18. Epstein S.P., Chen D., Asbell P.A. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 2009, 25:415-424.
19. Jaenen N., Baudouin C., Pouliquen P., Manni G., Figueiredo A., Zeyen T. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 2007, 17:341-349.
20. Pisella P.J., Pouliquen P., Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative-free glaucoma medication. Br J Ophthalmol 2002, 86:418-423.
21. Ayaki M., Yaguchi S., Iwasawa A., Koide R. Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells. Clin Experiment Ophthalmol 2008, 36:553-559.